143 related articles for article (PubMed ID: 26365980)
1. Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia.
Zhang L; Jiao L; Wang SJ
Chin Med J (Engl); 2015 Sep; 128(18):2551-2. PubMed ID: 26365980
[No Abstract] [Full Text] [Related]
2. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
Hundae A; Peskoe S; Grimsley E; Patel S
South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
[TBL] [Abstract][Full Text] [Related]
3. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine alone for severe immune thrombocytopenic purpura associated with systemic lupus erythematosus.
Blasco LM
Lupus; 2013 Jun; 22(7):752-3. PubMed ID: 23698017
[No Abstract] [Full Text] [Related]
5. Evan's syndrome complicating multicentric Castleman's disease -- dramatic response to rituximab.
Quinn JP; Gilligan OM; Horgan M
Eur J Haematol; 2004 Nov; 73(5):384-5. PubMed ID: 15458520
[No Abstract] [Full Text] [Related]
6. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
Lee JW; Kim HA; Sung JM; Suh CH
Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
[No Abstract] [Full Text] [Related]
7. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus.
Peñacoba Toribio P; Córica Albani ME; Mayos Pérez M; Rodríguez de la Serna A
Reumatol Clin; 2014; 10(5):325-7. PubMed ID: 24315464
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
Tambralli A; Beukelman T; Cron RQ; Stoll ML
J Rheumatol; 2015 Mar; 42(3):541-6. PubMed ID: 25593242
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of autoimmune thrombocytopenic purpura with rituximab in a dialysis patient with systemic lupus erythematosus.
Lee SY; Hsu PY; Juan KC; Chang H; Huang WH; Lai PC
Int Immunopharmacol; 2010 May; 10(5):632-4. PubMed ID: 20172055
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus and Castleman's disease.
Suwannaroj S; Elkins SL; McMurray RW
J Rheumatol; 1999 Jun; 26(6):1400-3. PubMed ID: 10381064
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
Nakayama K; Tamimoto Y; Nakayama T
Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
[TBL] [Abstract][Full Text] [Related]
16. Membranoproliferative glomerulonephritis in the setting of multicentric angiofollicular lymph node hyperplasia (Castleman's disease) complicated by Evan's syndrome.
Gakiopoulou H; Korkolopoulou P; Paraskevakou H; Marinaki S; Voulgarelis M; Stofas A; Lelouda M; Lazaris AC; Boletis J; Patsouris E
J Clin Pathol; 2010 Jun; 63(6):552-4. PubMed ID: 20439324
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Patients with Castleman's Disease Complicated Systemic Lupus Erythematosus.
Zhang L; Cao XX; Wang SJ; Zhou DB; Li J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):543-547. PubMed ID: 27825411
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study.
Scherlinger M; Carcaud C; Truchetet ME; Barnetche T; Duffau P; Couzi L; Seneschal J; Blanco P; Lazaro E; Richez C
Ann Rheum Dis; 2019 Jul; 78(7):1007-1010. PubMed ID: 30610064
[No Abstract] [Full Text] [Related]
19. Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia.
Lepore L; Salvatore CM; Pahor T; Kiren V; Ventura A
Clin Exp Rheumatol; 2000; 18(4):535. PubMed ID: 10949737
[No Abstract] [Full Text] [Related]
20. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Junga Z; Stitt R; Tracy C; Keith M
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
